TARA Biosystems CEO and leadership

Misti Ushio is a Board Member at AgBiome, Board Observer at Metabolon Inc, and Member of the Board of Directors at Petra Pharma Corporation and is based in New York City, New York. She has worked as Chief Strategy Officer at 180 DEGREE CAPITAL CORP, VP/Associate at 180 DEGREE CAPITAL CORP, and Managing Director & Chief Strategy Officer at Harris & Harrris Group. Misti works or has worked as MEMBER at Nanotechnology Inst Corporate Advisory Group and Board Member at ISB Accelerator Corp. She attended Johns Hopkins University, Bank of Canada, and Lehigh University.

Inspired leader with a unique background that combines accomplishments as a corporate executive, scientist, and board member of not-for-profit organizations.

• Effective builder and manager of cross-functional R &D teams.

• Global expertise in building and managing external strategic partnerships. Spearheaded initiative to create a cost effective, innovative drug discovery pipeline via external partnerships with academic institutions, biotechnology firms, and contract research labs worldwide

• Leader in the discovery and development of new drugs, including Zetia and Vytorin which generate $3 billion in annual sales.

• Patent holder, and author of more than 60 manuscripts in peer reviewed journals.

•

Misti Ushio is a Board Member at AgBiome, Board Observer at Metabolon Inc, and Member of the Board of Directors at Petra Pharma Corporation and is based in New York City, New York. She has worked as Chief Strategy Officer at 180 DEGREE CAPITAL CORP, VP/Associate at 180 DEGREE CAPITAL CORP, and Managing Director & Chief Strategy Officer at Harris & Harrris Group. Misti works or has worked as MEMBER at Nanotechnology Inst Corporate Advisory Group and Board Member at ISB Accelerator Corp. She attended Johns Hopkins University, Bank of Canada, and Lehigh University.